Hepatoblastoma—The Evolution of Biology, Surgery, and Transplantation
The most common primary malignant liver tumor of childhood, hepatoblastoma has increased in incidence over the last 30 years, but little is still known about its pathogenesis. Discoveries in molecular biology provide clues but have yet to define targeted therapies. Disease-free survival varies accor...
Main Authors: | Irene Isabel P. Lim, Alexander J. Bondoc, James I. Geller, Gregory M. Tiao |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-12-01
|
Series: | Children |
Subjects: | |
Online Access: | http://www.mdpi.com/2227-9067/6/1/1 |
Similar Items
-
Quality of Life Outcomes for Patients Who Underwent Conventional Resection and Liver Transplantation for Locally Advanced Hepatoblastoma
by: Zishaan Farooqui, et al.
Published: (2023-05-01) -
Retreatment with Cisplatin May Provide a Survival Advantage for Children with Relapsed/Refractory Hepatoblastoma: An Institutional Experience
by: Katherine M. Somers, et al.
Published: (2023-08-01) -
HEPATOBLASTOMA REQUIRING LIVER TRANSPLANTATION. A CASE REPORT
by: Roxana-Cristina Mares, et al.
Published: (2019-03-01) -
Risk for Recurrence in Long-Term Follow-Up of Children after Liver Transplantation for Hepatoblastoma or Hepatocellular Carcinoma
by: Marek Stefanowicz, et al.
Published: (2024-02-01) -
Phosphorylation-Mediated Activation of β-Catenin-TCF4-CEGRs/ALCDs Pathway Is an Essential Event in Development of Aggressive Hepatoblastoma
by: Ruhi Gulati, et al.
Published: (2022-12-01)